The Hang Seng Index rose 2.25% this week to close at 25407.89.

The IPO market has gradually picked up this week, with a total of nine IPOs, including Asia's largest artificial intelligence software provider.SenseTime, the second largest online logistics platform in mainland China--GOGOXAnd China's largest digital chronic disease management solution provider--Zhiyun Health。

This week onlyHelensA new stock has been reported, there is no new share offering, a total of 1 new shares listed on the market.

New shares listed this week$Centrum Medical-B (06669.HK) $The performance was poor, closing down 24.79% in the dark market, losing HK $5900 per hand, and closing down 26.05% on the first day. In the previous public offering phase, the number of applicants for the first Ruida Medical Public Placement was 310600, with a success rate of 3%.

There are a total of nine IPOs this week:

Zhiyun HealthFounded in 2014, it is an one-stop chronic disease management and intelligent medical platform in China. It is currently providing services to nearly thousands of hospitals and tens of thousands of pharmacies across the country through independently developed hospital SaaS system, drugstore SaaS system, and advanced Internet hospital platform, radiating 500m chronically ill patients. According to the Frost Sullivan report, Zhiyun Health is the largest digital chronic disease management solution provider in China based on the number of SaaS deployments in Chinese hospitals and pharmacies as of December 31, 2020, and the number of online prescriptions opened through Zhiyun Health's service during the six-month period ended June 30, 2021.

SenseTimeFounded in 2014, is an AI software company specializing in computer vision and deep learning technology, independently developed and established a deep learning platform and supercomputing center, covering smart business, smart city, smart life, smart car four sectors. In 2020, Shangtang Technology is the largest artificial intelligence software provider in Asia and the largest computer vision software provider in China by revenue. It is also known as the four Little Dragons of AI in the industry along with Xanshi Technology, Yitu Technology and Yuncong Technology.

GOGOXIs Asia's leading online logistics platform in the same city, affiliated to the Home Group. The company operates in more than 340 cities in five Asian countries and regions and owns and operates two brands in online intercity logistics services: GOGOX in mainland China and GOGOX in other Asian countries and regions. Among them, GOGOX is the largest inter-city logistics platform in Hong Kong, China in 2020, and has expanded its footprint to overseas markets, including Singapore, South Korea and India, while "GOGOX" is the second largest logistics platform in the same city in mainland China.

New pulse medical treatmentIs a leading technology-driven and innovative Chinese Heart Valve device Company, at the forefront of the fast-growing and potential market for the treatment of structural heart disease, has established a comprehensive portfolio of products under development for transcatheter replacement and repair of all four valves in the human heart, as well as a comprehensive portfolio of invasive cardiac surgery aids. As of the latest practical date, Newpulse Medical's product development pipeline includes 16 products under development, and the core product, Prizvalve ®, is undergoing confirmatory clinical trials.

SamoyeyunIt is a leading independent cloud service technology solution provider in China. According to the data of Zuoshi Consulting, the company is the third largest independent cloud service technology solution provider in China in terms of cloud service technology solution revenue in 2020. As of April 30, 2021, the "Digital Intelligence Samoyun platform" has connected about 73.7 million small and micro merchants and customers, 50 financial institutions, 530 enterprises in different industries, 1470 Internet platforms and 70 data providers, forming a high-quality private domain traffic pool.

Medicine Jie AnkangFounded in 2014, is an R & D-oriented, clinical-stage global biopharmaceutical company focused on the discovery and development of innovative small molecule therapies for oncology, inflammation and cardiovascular disease. According to Frost Sullivan, Jie Ankang is one of the first Chinese developers committed to innovative small molecules to establish a global R & D and clinical development platform.

Debao projectMainly providing electrical and mechanical services in Hong Kong, the company ranks seventh among the competitors in the electrical and mechanical services industry in Hong Kong in terms of revenue in 2019. According to the Ipsos report, as at 21 August 2021, of the 183 contractors registered by the Development Board with one or more electrical and mechanical specialist contractor licences, only 15 have obtained all the highest category 3 electrical and mechanical specialist contractor licences, and Debao Engineering Holdings is one of the registered contractors.

Fujing ChinaIt is the largest producer of potted vegetables and agricultural products in Shandong Province. In 2020, the company's market share in Shandong Province was 16.0% in terms of sales revenue. Fujing China has been operating the business of growing and selling potted vegetables and agricultural products in Laixi, Qingdao, Shandong Province since 2012, and is one of the pioneers of potted vegetable producers in Shandong Province.

Baolong Housing Trust FundIt is a Hong Kong collective investment scheme in the form of unit trusts and has been approved under section 104 of the Securities and Futures Ordinance to own and invest in quality income-generating commercial properties in China.

A total of 1 new shares have been reported this week:

HelensIt is the largest pub chain in China, and Helens ranks first in the Chinese pub industry by revenue in 2020, accounting for 1.1% of the market share. The company has been operating pubs under the brand name "Helen's". As of August 21, 2021, the number of Helen's pubs in first-tier, second-tier, third-tier and below cities in China was 66, 296 and 165 respectively, accounting for 12.5%, 56.1% and 31.3% of the total number of pubs as of the same day, respectively.

Helen's 's own drinks mainly include Helens draft Beer, Helens Fruit Beer, Helens Milk Beer and so on. At the same time, the company also provides young customers with widely known third-party brand products, including Budweiser, Corona, 1664, Yege, etc., to provide customers with a wide range of product choices.

A total of 1 new shares have been listed this week:

$Centrum Medical-B (06669.HK) $In the dark market, it closed down 24.79%, losing HK $5900 per hand, closing down 26.05% on the first day, and closing down 23.95% at HK $18.10 as of Friday. In the previous public offering phase, the number of applicants for the first Ruida Medical Public Placement was 310600, with a success rate of 3%.